Klareskog Lars, Padyukov Leonid, Lorentzen Johnny, Alfredsson Lars
Rheumatology Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Nat Clin Pract Rheumatol. 2006 Aug;2(8):425-33. doi: 10.1038/ncprheum0249.
Rheumatoid arthritis (RA) is a complex disease in which environmental agents are thought to interact with genetic factors that influence susceptibility. This interaction triggers immunologic events that eventually result in the clinical signs of arthritis. Knowledge of the chain of etiological events that lead to the development of RA is incomplete. In this review, we describe the experimental approaches that are used to address the issue of gene-environment interactions in the etiology of RA, and discuss relevant examples of such interactions. We focus on how smoking, the best-known environmental risk factor for RA, interacts with HLA-DR shared epitope genes, the main genetic risk factors for RA, and result in a high risk of RA in individuals exposed to both of these risk factors. From these and other related findings, we can begin to define the distinct environmental risk factors (such as smoking) that in certain genetic contexts (for example, the presence of HLA-DR shared epitope alleles) can trigger immune reactions (such as autoantibodies to citrullinated peptides) many years before onset of RA, and consider how these immune reactions might contribute to clinical symptoms in a subset of affected patients. Increased knowledge about these and other events involved in the development of RA should enable the design of new tools for suppressing RA pathogenesis before the onset of disease.
类风湿性关节炎(RA)是一种复杂的疾病,其中环境因素被认为与影响易感性的遗传因素相互作用。这种相互作用引发免疫反应,最终导致关节炎的临床症状。导致RA发生的病因事件链的相关知识尚不完整。在本综述中,我们描述了用于解决RA病因中基因 - 环境相互作用问题的实验方法,并讨论了此类相互作用的相关实例。我们重点关注吸烟(RA最知名的环境风险因素)如何与RA的主要遗传风险因素HLA - DR共享表位基因相互作用,并导致同时暴露于这两种风险因素的个体患RA的风险增加。从这些以及其他相关发现中,我们可以开始确定在某些遗传背景下(例如存在HLA - DR共享表位等位基因)能够在RA发病前多年触发免疫反应(如针对瓜氨酸化肽的自身抗体)的特定环境风险因素(如吸烟),并思考这些免疫反应如何可能导致一部分受影响患者出现临床症状。对这些以及其他参与RA发展的事件的更多了解,应该能够设计出新的工具,在疾病发作前抑制RA的发病机制。